In recent years, Suboxone, a medication widely prescribed for opioid addiction treatment, has become the focal point of a series of legal battles across the United States. At the heart of these disputes is the alarming connection between Suboxone and severe dental...
Intake
The Massive Ozempic Potential Plaintiff Pool & Injury Spectrum
The litigation surrounding GLP-1 receptor agonists (GLP-1 RA), including Ozempic and Wegovy, represents a significant chapter in the ongoing scrutiny of pharmaceutical safety and marketing ethics. Stemming from allegations that severe gastrointestinal side effects...
Devin’s Unexpected Road to Legal Marketing
Recently, for the first time publicly, I shared about my journey into legal marketing and how it didn’t start in a boardroom or at a networking event, but rather, on the side of a road following a hit-and-run accident on my way to fly to meet with Wells Fargo, a major...
The Latest in Uber Sex Assault Mass Tort Litigation: An Overview
As the legal landscape for rideshare companies continues to evolve, the Uber Sex Assault Mass Tort litigation has garnered significant attention. Following the formation of the Multidistrict Litigation (MDL) last year, Uber's attempt to dismantle the MDL was met with...
Enough is Enough: Stop Advertising Camp Lejeune Already
As we reflect on the tidal wave of advertising that has characterized the Camp Lejeune litigation in 2023, a stark realization emerges: the industry has not only reached a saturation point but has also ventured into the territory of 'The Big Fake.' With an astounding...
Devin Downey at 50: Reflecting on a Big Pivot from Fortune 500 Brand Advertising to Legal Marketing
As Devin Downey celebrated his 50th year, his career narrative emerges as a compelling testament to two decades of innovative work in brand advertising, culminating in a shift to legal marketing and intake. This transition from the dynamic world of top digital and...